Medherant | EU-Startups

Home Medherant

Medherant

Category

Business Description

Medherant is a clinical stage drug delivery company developing products for pain and CNS diseases. The Company was founded by Professor David Haddleton and the University of Warwick in 2015 based on their world-leading expertise in bioadhesives and polymer chemistry. Medherant has developed a novel drug-in-adhesive transdermal delivery system, the TEPI® Patch, using a proprietary adhesive which it has exclusively licensed from Bostik.

Based in

Coventry

Tags

Pharmaceuticals, CNS diseases, eHealth, Healthcare

Founded

2015

Website

www.medherant.co.uk

Articles about Medherant:

September 27, 2016 MedTech startup Medherant closes £1.5M financing round for its transdermal drug delivery platform

💡 You're a corporate or investor and looking for startups that are innovating in the same market as Medherant? We're happy to assist you with our Startup Sourcing service.